6月24日，荣昌生物盘中上涨5.31%，报70.5港元/股，成交额1.21亿港元。
消息面上，港股生物科技板块连续第二日集体反弹，科伦博泰生物涨8.49%、康方生物涨5.56%、三生制药涨5.17%、信达生物涨4.9%，行业情绪持续修复。此外，公司此前公告1.93亿股首发限售股将于7月1日上市流通，占总股本34.16%，但因公司未满足现金分红条件，解禁股东不得通过集中竞价或大宗交易方式减持A股股份，实际抛压预期大幅缓解，市场对解禁冲击的担忧进一步消退。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.